Simcere Pharmaceutical Group is China's leading R&D-driven pharmaceutical company. It has been ranked amongst the top 100 pharmaceutical companies in China and in the top 10 of the most innovative pharmaceutical companies in China for several consecutive years. Simcere was the first Chinese biological and chemical pharmaceutical company to be listed on the New York Stock Exchange. The national key laboratory for translational medicine and innovative drugs has been approved by the Ministry of Science and Technology. We are striving to make new medicines available to our patients sooner.